Zurig 80mg (Febuxostat)

Overview

Zurig 80mg contains Febuxostat, a potent inhibitor of xanthine oxidase employed mainly for the control of hyperuricemia in patients suffering from Gout. Febuxostat efficiently reduces serum levels of uric acids by blocking the enzyme that is which is responsible for uric acid’s production, which reduces flare-ups caused by gout as well as preventing the growth of crystals of urate in joints and tissues.

Zurig 80mg is a practical oral option for those suffering from chronic gout that need longer-term treatment to lower urate levels, specifically patients who have difficulty or are not adequately controlled by allopurinol.

Active Ingredient

• Febuxostat 80mg

Indications

Zurig 80mg is indicated for:

• Treatment for hyperuricemia in patients suffering from Gout.
• Preventing flare-ups due to gout through keeping serum uric acid levels below targeted levels.
• The treatment of patients unresponsive to or not adequately managed with allopurinol.

Mechanism of Action

Febuxostat specifically blocks the enzyme xanthine oxide which is an enzyme responsible for the conversion of hypoxanthine as well as xanthine to Uric acid. In reducing uric acid’s production, Febuxostat lowers serum urate levels. It also helps to break down urate crystals and prevents their formation in tissues and joints, thereby reducing the signs and progression of Gout.

Dosage and Administration

• The dose recommended for you is 80 mg twice daily.
• Febuxostat tablets are able to be consumed in combination with and without meals.
• If you have a patient with mild or moderate renal or liver impairment, no initial dose adjustment will be required. However, it is recommended to monitor the patient regularly.
• It is generally a long-term process as determined by your doctor, on the basis of the levels of uric acid in serum and the clinical reaction.
• The dosage can be altered (up to 120 mg daily) when serum uric acid levels aren’t met.

Benefits

• Effectively reducing blood uric acid levels.
• Dosing once a day for greater patient acceptance.
• Ideal for patients suffering from kidney impairment, in which allopurinol might be an unsuitable treatment.
• Reduction in the severity and frequency of flare-ups.
• The quality of life is improved for those who suffer from chronic gout.

Side Effects

Common side effects may include:

• Nausea
• Joint pain (arthralgia)
• Rash
• Elevated liver enzymes
• Headache

Serious but rare side effects:

• Liver toxicity
• Cardiovascular events (Patients with heart disease should be closely monitored)
• Hypersensitivity reactions (including severe skin reactions)

Contraindications

• Known hypersensitivity to Febuxostat, or any of its components.
• Concomitant use with azathioprine, mercaptopurine, or theophylline.
• Severe liver impairment.
• Pregnancy and breastfeeding.

Warnings and Precautions

• Monitor liver function testing periodically throughout treatment.
• Patients with a cardiovascular history should be treated cautiously.
• If you notice signs of skin hypersensitivity, discontinue use.
• To prevent the formation of kidney stones, it is important to drink enough water.
• It is not indicated to treat acute attacks of gout. Start treatment only when the acute attack has passed.
• Early treatment of gout may require the use of NSAIDs or colchicine to reduce flare-ups.

Drug Interactions

• The plasma levels of drugs that are metabolized with xanthine oxidase can be increased by Febuxostat.
• Concomitant administration of azathioprine (mercaptopurine), theophylline, or mercaptopurine can increase toxicity.
• Can interact with anticoagulants. Monitoring is recommended.
• Use with caution if you are taking cyclosporine or other immunosuppressive drugs.

Use in Special Populations

• Elderly: There is no need to adjust dosage, but you should monitor any adverse reactions.
• Renal impairment: Use with caution in patients who have mild or moderate renal impairment. Monitor serum uric levels.
• Pregnancy and lactation: Not recommended.
• Pediatric: No safety and efficacy established.

Storage Instructions

• Keep Zurig 80mg below 30 °C and in a place that is dry.
• Avoid direct sunlight and moisture.
• Children should not be allowed to touch the product.

Packaging

Zurig 80mg comes in bottles of 30 tablets that clearly indicate the dosage.

Frequently Asked Questions (FAQs)

Q1: How long does it take for Zurig to work?

A: The uric levels may not drop significantly for several weeks or months.

Q2: Can Zurig be taken with food?

A: Yes, You can take it with or without food.

Q3: Should I stop taking Zurig if I experience a gout flare?

A: No. Keep up the prescribed therapy. Initially, gout flares may occur, but they usually subside over time.

Conclusion

Zurig 80mg (Febuxostat) is an effective and reliable treatment for patients suffering from gout or hyperuricemia. It offers a targeted solution to prevent complications and reduce the production of uric acid. The convenient daily dosing schedule and its suitability for renal-impaired patients make this a good choice for managing gout over the long term. Use under regular medical monitoring and always use with supervision.